FDA Inspection
Apotex Inc.Apotex Inc. – FDA Inspection, Oct 26, 2012
Record Details
This FDA Inspection record concerns Apotex Inc., with an inspection on October 26, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Apotex Inc.
- Inspection Date
- October 26, 2012
- Product Type
- Drugs
View Company Profile
ID · f8bd1fcb-7a40-4bb5-8b11-8ad1e9defd0b
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 813385
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Apotex Inc.
10| Date | Classification | Office | Project area |
|---|---|---|---|
| May 9, 2025 | OAI | Office of Inspections and Investigations | Drug Quality Assurance |
| March 8, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 24, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 14, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 28, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Apotex Inc.
- FDA Inspection 1269710 - 2025-05-09
- FDA Inspection 1231036 - 2024-03-08
- FDA Inspection 1203170 - 2023-03-24
- FDA Inspection 1179507 - 2022-09-14
- FDA Inspection 1098988 - 2019-06-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.